T cell Homeostatic Imbalance in Placentae from Women with HIV in the absence of Vertical Transmission.
暂无分享,去创建一个
L. Myer | C. Gray | S. Khoo | H. Jaspan | K. Pillay | M. Lamorde | T. Tilburgs | T. Malaba | R. Chakraborty | N. Ikumi | E. Enninga | Sonwabile Dzanibe
[1] L. Myer,et al. Differential impact of antiretroviral therapy initiated before or during pregnancy on placenta pathology in HIV-positive women. , 2021, AIDS.
[2] L. Serghides,et al. Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies , 2020, Human reproduction.
[3] C. Sabin,et al. CD4+:CD8+ T Cell Ratio Normalization and the Development of AIDS Events in People with HIV Starting Antiretroviral Therapy , 2020, AIDS research and human retroviruses.
[4] L. Myer,et al. Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial. , 2020, The lancet. HIV.
[5] C. Gray,et al. Maternal T Cells in the Human Placental Villi Support an Allograft Response during Noninfectious Villitis , 2020, The Journal of Immunology.
[6] L. Myer,et al. Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study) , 2019, PLoS medicine.
[7] R. Pique-Regi,et al. Single cell transcriptional signatures of the human placenta in term and preterm parturition , 2019, bioRxiv.
[8] M. Diamond,et al. Immune responses at the maternal-fetal interface , 2019, Science Immunology.
[9] L. Ernst. Maternal vascular malperfusion of the placental bed , 2018, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[10] J. Sled,et al. HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation , 2018, Scientific Reports.
[11] G. Siberry,et al. Lymphocyte subsets in HIV-exposed uninfected infants and HIV-unexposed uninfected infants. , 2017, The Journal of allergy and clinical immunology.
[12] Eric W. Cross,et al. Antigen-inexperienced memory CD8+ T cells: where they come from and why we need them , 2017, Nature Reviews Immunology.
[13] P. Schubert,et al. Placental pathology in HIV infection at term: a comparison with HIV‐uninfected women , 2017, Tropical medicine & international health : TM & IH.
[14] N. Funderburg,et al. Inflammation, Immune Activation, and Antiretroviral Therapy in HIV , 2017, Current HIV/AIDS Reports.
[15] A. Marchant,et al. The Immune System of HIV-Exposed Uninfected Infants , 2016, Front. Immunol..
[16] B. Haynes,et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection , 2016, PLoS pathogens.
[17] C. Jones,et al. HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. , 2016, The Lancet. Infectious diseases.
[18] Anthony Odibo,et al. Hemodynamic aspects of normal human feto‐placental (umbilical) circulation , 2016, Acta obstetricia et gynecologica Scandinavica.
[19] Neil J Sebire,et al. Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement. , 2016, Archives of pathology & laboratory medicine.
[20] B. Stranger,et al. Human HLA-G+ extravillous trophoblasts: Immune-activating cells that interact with decidual leukocytes , 2015, Proceedings of the National Academy of Sciences.
[21] N. Lapointe,et al. Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency , 2014, BMC Infectious Diseases.
[22] E. Nduati,et al. HIV‐exposed uninfected children: a growing population with a vulnerable immune system? , 2014, Clinical and experimental immunology.
[23] M. Kilby,et al. The immunological basis of villitis of unknown etiology - review. , 2013, Placenta.
[24] J. Strominger,et al. CD8+ Effector T Cells at the Fetal–Maternal Interface, Balancing Fetal Tolerance and Antiviral Immunity , 2013, American journal of reproductive immunology.
[25] D. Nixon,et al. Decay Kinetics of HIV-1 Specific T Cell Responses in Vertically HIV-1 Exposed Seronegative Infants , 2012, Front. Immun..
[26] K. Metze,et al. The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns , 2011, BMC infectious diseases.
[27] G. Kaplan,et al. Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life. , 2009, Clinical immunology.
[28] Dajin Li,et al. Human Trophoblasts Recruited T Lymphocytes and Monocytes into Decidua by Secretion of Chemokine CXCL16 and Interaction with CXCR6 in the First-Trimester Pregnancy1 , 2008, The Journal of Immunology.
[29] G. Dawe,et al. Cell Migration from Baby to Mother , 2007, Cell adhesion & migration.
[30] L. Mofenson,et al. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study. , 2006, The Journal of infectious diseases.
[31] S. Henson,et al. Memory T-cell homeostasis and senescence during aging. , 2005, Advances in experimental medicine and biology.
[32] J. Nielsen,et al. Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. , 2001, Blood.
[33] M. Clerici,et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. , 2000, Blood.
[34] J. Pudney,et al. Gamma-Delta T Cells in Midgestation Human Placental Villi , 2000, Gynecologic and Obstetric Investigation.